Addressing Multimorbidity in Evidence Integration and Synthesis
- 18 January 2014
- journal article
- review article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 29 (4) , 661-669
Abstract
To minimize bias, clinical practice guidelines (CPG) for managing patients with multiple conditions should be informed by well-planned syntheses of the totality of the relevant evidence by means of systematic reviews and meta-analyses. However, deficiencies along the entire evidentiary pathway hinder the development of evidence-based CPGs. Published reports of trials and observational studies often do not provide usable data on treatment effect heterogeneity, perhaps because their design, analysis and presentation is seldom geared towards informing on how multimorbidity modifies the effect of treatments. Systematic reviews and meta-analyses inherit all the limitations of their building blocks and introduce additional of their own, including selection biases at the level of the included studies, ecological biases, and analytical challenges. To generate recommendations to help negotiate some of the challenges in synthesizing the primary literature, so that the results of the evidence synthesis is applicable to the care of those with multiple conditions. Informal group process. We have built upon established general guidance, and provide additional recommendations specific to systematic reviews that could improve the CPGs for multimorbid patients. We suggest that following the additional recommendations is good practice, but acknowledge that not all proposed recommendations are of equal importance, validity and feasibility, and that further work is needed to test and refine the recommendations.Keywords
This publication has 69 references indexed in Scilit:
- Canadian guidelines for clinical practice: an analysis of their quality and relevance to the care of adults with comorbidityBMC Family Practice, 2011
- Examining the Evidence: A Systematic Review of the Inclusion and Analysis of Older Adults in Randomized Controlled TrialsJournal of General Internal Medicine, 2011
- Multivariate meta‐analysis: Potential and promiseStatistics in Medicine, 2011
- Grading quality of evidence and strength of recommendations for diagnostic tests and strategiesBMJ, 2008
- Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological studyBMJ, 2008
- Eligibility Criteria of Randomized Controlled Trials Published in High-Impact General Medical JournalsJAMA, 2007
- Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid DiseasesJAMA, 2005
- Combination of direct and indirect evidence in mixed treatment comparisonsStatistics in Medicine, 2004
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983